Publications by authors named "Wesley Yin"

Claim this Profile
T
The Impact of Financial Assistance Programs on Health Care Utilization: Evidence from Kaiser Permanente.
Alyce Adams, Raymond Kluender, Neale Mahoney, Jinglin Wang, Francis Wong, Wesley Yin

Am Econ Rev Insights· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in Medical Debt During the COVID-19 Pandemic.
Benedict Guttman-Kenney, Raymond Kluender, Neale Mahoney, Francis Wong, Xuyang Xia, Wesley Yin

JAMA Health Forum· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized Telephone Outreach Increased Health Insurance Take-Up For Hard-To-Reach Populations, But Challenges Remain.
Rebecca Myerson, Nicholas Tilipman, Andrew Feher, Honglin Li, Wesley Yin

Health Aff (Millwood)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medical Debt in the US From 2009 to 2020-Reply.
Neale Mahoney, Francis Wong, Wesley Yin

JAMA· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medical Debt in the US, 2009-2020.
Raymond Kluender, Neale Mahoney, Francis Wong, Wesley Yin

JAMA· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Breast Cancer Disease Progression and Workplace Productivity in the United States.
Wesley Yin, Ruslan Horblyuk, Julia Jane Perkins, Steve Sison, Greg Smith

J Occup Environ Med· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insurers' Negotiating Leverage and the External Effects of Medicare Part D.
Darius Lakdawalla, Wesley Yin

Rev Econ Stat· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Value of survival gains in chronic myeloid leukemia.
Wesley Yin, John R Penrod, Ross Maclean, Darius N Lakdawalla, Thomas Philipson

Am J Manag Care· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Valuing health technologies at NICE: recommendations for improved incorporation of treatment value in HTA.
Dana Goldman, Darius Lakdawalla, Tomas J Philipson, Wesley Yin

Health Econ· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Medicare Part D on Medicare-Medicaid dual-eligible beneficiaries' prescription utilization and expenditures.
Anirban Basu, Wesley Yin, G Caleb Alexander

Health Serv Res· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
R&D policy, agency costs and innovation in personalized medicine.
Wesley Yin

J Health Econ· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of the Medicare Part D prescription benefit on generic drug use.
James X Zhang, Wesley Yin, Shawn X Sun, G Caleb Alexander

J Gen Intern Med· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Market incentives and pharmaceutical innovation.
Wesley Yin

J Health Econ· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of the Medicare Part D prescription benefit on drug utilization and expenditures.
Wesley Yin, Anirban Basu, James X Zhang, Atonu Rabbani, David O Meltzer

Ann Intern Med· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis